Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro-Reference-Cited by-同舟云学术

Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro

Published:2021-01 Issue: Volume:163 Page:105255
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Clementi Nicola,Scagnolari Carolina^ORCID,D’Amore Antonella,Palombi Fioretta^ORCID,Criscuolo Elena,Frasca Federica,Pierangeli Alessandra^ORCID,Mancini Nicasio,Antonelli Guido,Clementi Massimo,Carpaneto Armando,Filippini Antonio^ORCID

Funder

Ministero della Salute

Publisher

Elsevier BV

Subject

Pharmacology

Reference19 articles.

1. Candidate drugs against SARS-CoV-2 and COVID-19;McKee;Pharmacol. Res.,2020

2. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2;Hoffmann;Nature,2020

3. Could the Inhibition of Endo-Lysosomal Two-Pore Channels (TPCs) by the Natural Flavonoid Naringenin Represent an Option to Fight SARS-CoV-2 Infection?;Filippini;Front. Microbiol.,2020

4. Naringenin impairs two-pore channel 2 activity and inhibits VEGF-Induced angiogenesis;Pafumi;Sci. Rep.,2017

5. A perspective on the modulation of plant and animal two pore channels (TPCs) by the flavonoid naringenin;Benkerrou;Biophys. Chem.,2019

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro study on efficacy of SKF7®, a Malaysian medicinal plant product against SARS-CoV-2;BMC Complementary Medicine and Therapies;2024-09-11

2. COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals;International Journal of Molecular Sciences;2024-08-03

3. The Molecular Mechanisms and Therapeutic Potential of Cranberry, D-Mannose, and Flavonoids against Infectious Diseases: The Example of Urinary Tract Infections;Antibiotics;2024-06-26

4. Metabolic engineering ofAcinetobacter baylyiADP1 for naringenin production;2024-06-06

5. Naringenin modifies T-helper responses and macrophage activities in BALB/c mice;AVICENNA J PHYTOMEDI;2024